Editorial Article
Integrating LC-MS and ligand binding assays to meet bioanalytical demands
How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics
Through extensive research, experimentation, and clinical trials, experts in the field of drug discovery and development identify promising biopharmaceutical or pharmaceutical drug candidates, optimize their efficacy and safety profiles, and navigate regulatory processes for eventual market approval. From innovative therapies to groundbreaking treatments, this dynamic scientific field plays a pivotal role in revolutionizing medicine and saving lives.
How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics